The problem of human immunodeficiency virus (HIV) infection and transplantation. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The problem of human immunodeficiency virus (HIV) infection and transplantation.

Transpl Int. 1988 Apr;1(1):36-42. Unique Identifier : AIDSLINE MED/89322560
Rubin RH; Tolkoff-Rubin NE; Infectious Disease, Units of the Medical Service, Massachusetts; General Hospital, Boston.


Abstract: The problem of human immunodeficiency virus (HIV) infection and that of the acquired immunodeficiency syndrome (AIDS) are becoming increasingly important in clinical transplantation. The epidemiologic characteristics of this infection are important factors in determining the impact of this infection on transplant patients: in particular, the presence of a transmissible virus in the blood, tissues, and body fluids of even asymptomatic individuals for prolonged periods; the role of lymphocyte activation in accelerating the pace and effects of HIV infection, with the transplant patient having more reasons for lymphocyte activation than other patient categories; and the possible contributions of immunosuppressive therapy to the course of HIV infection. Already, at least 20 cases of primary HIV infection conveyed by infected blood or allografts at the time of transplant have been noted; a similar number of transplants have been carried out in asymptomatic carriers of the virus. The initial impression is that the course of HIV infection in these patients is accelerated, but information is incomplete and an international registry for the study of this problem has been established.
Keywords: Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/ETIOLOGY/ *TRANSMISSION Carrier State Enzyme-Linked Immunosorbent Assay Human HIV Antibodies/ISOLATION & PURIF Transplantation/*ADVERSE EFFECTS JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL

KWDacquiredimmunodeficiencysyndrome/epidemiology/etiology/KWDtransmissioncarrierstateenzyme-linkedimmunosorbentassayhumanhivantibodies/isolation&puriftransplantation/KWDadverseeffectsjournalarticlereviewreview,tutorial
891130
M89B0568


Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .